See the latest Coronavirus Information including vaccinations, testing sites, visitation restrictions, and more.
Adults (18-65), Geriatrics (65+)
Adults (18-65), Geriatrics (65+)
Perelman Center for Advanced Medicine
West Pavilion, 2nd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Stephen J Bagley, Arati S Desai, Gerald P Linette, Carl H June, Donald M O'Rourke.: CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges Neuro Oncol 20 (11): 1429-1438. ,2020.
Mac Lean P Nasrallah, Arati Desai, Donald M O'Rourke, Lea F Surrey, Joel M Stein.: A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features Acta Neuropathol Commun
8 (1): 115,2020.
Hamed Akbari, Saima Rathore, Spyridon Bakas, MacLean P Nasrallah, Gaurav Shukla, Elizabeth Mamourian, Martin Rozycki, Stephen J Bagley, Jeffrey D Rudie, Adam E Flanders, Adam P Dicker, Arati S Desai, Donald M O'Rourke, Steven Brem, Robert Lustig, Suyash Mohan, Ronald L Wolf, Michel Bilello, Maria Martinez-Lage, Christos Davatzikos.: Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma. Cancer
126 (11): 2625-2636,2020.
Stephen J Bagley, Arati S Desai, MacLean P Nasralla, Donald M O'Rourke.: Immunotherapy and Response Assessment in Malignant Glioma: Neuro-oncology Perspective Review 29 (2): 95-102,2020.
Fraser Henderson Jr, Steven Brem, Donald M O'Rourke, MacLean Nasrallah, Vivek P Buch, Anthony J Young, Robert K Doot, Austin Pantel, Arati Desai, Stephen J Bagley, S Ali Nabavizadeh.: 18 F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling Neurooncol Pract
7 (2): 152-157,2020.
Sumei Wang, Donald M O'Rourke, Sanjeev Chawla, Gaurav Verma, MacLean P Nasrallah, Jennifer J D Morrissette, Gabriela Plesa, Carl H June, Steven Brem, Eileen Maloney, Arati Desai, Ronald L Wolf, Harish Poptani, Suyash Mohan.: Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma Br J Cancer 120 (1): 54-56,2020.
Seyed Ali Nabavizadeh, Jeffrey B Ware, Samantha Guiry, MacLean P Nasrallah, Jazmine J Mays, Jacob E Till, Jasmin Hussain, Aseel Abdalla, Stephanie S Yee, Zev A Binder, Donald M O'Rourke, Steven Brem, Arati S Desai, Ronald Wolf, Erica L Carpenter, Stephen J Bagley.: Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma Neurooncol Adv
2 (1): vdaa016.,2020.
Stephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, Jacob E Till, Jeffrey B Ware, Scott Levy, Whitney Sarchiapone, Jasmin Hussain, Timothy Prior, Samantha Guiry, Theresa Christensen, Stephanie S Yee, MacLean P Nasrallah, Jennifer J D Morrissette, Zev A Binder, Donald M O'Rourke, Andrew J Cucchiara, Steven Brem, Arati S Desai, Erica L Carpenter.: Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study. Clin Cancer Res
26 (2): 397-407,2020.
Daniel I Hoffman, Kalil G Abdullah, Makayla McCoskey, Zev A Binder, Donald M O'Rourke, Arati S Desai, MacLean P Nasrallah, Ashkan Bigdeli, Jennifer J D Morrissette, Steven Brem, Stephen J Bagley.: Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma J Neurooncol
145 (2): 321-328,2019.
Igor Makhlin, Ryan D Salinas, Daniel Zhang, Fadi Jacob, Gou-Li Ming, Hongjun Song, Deeksha Saxena, Jay F Dorsey, MacLean P Nasrallah, Jennifer Jd Morrissette, Zev A Binder, Donald M O'Rourke, Arati S Desai, Steven Brem, Stephen J Bagley: Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma CNS Oncol
8 (3): CNS43. ,2019.
Division of Hematology Oncology Perelman Center for Advanced Medicine10th Floor, South PavilionOffice #10-3073400 Civic Center Boulevard
Patient appointments: 800-789-7366
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.